These outcomes, together with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,two support the idea of targeting ACKR3 as a novel way to modulate the opioid system, which could open up new therapeutic avenues for opioid-connected Diseases. (3) Besides in the event https://francism147pmh7.losblogos.com/profile